Discovering and Delivering Compassionate, Coordinated Care
At UMass Memorial Cancer Center of Excellence in Worcester, MA, we work in partnership with the University of Massachusetts Medical School to research new treatments for cancer. UMass Memorial is at the forefront of some of the nation’s most promising research and treatment programs. Through our Cancer Center Clinical Research Office (CRO), we perform breakthrough research and clinical trials to improve treatment and your quality of life.
Leukemia Trials Underway
Imatinib/Zileuton in CML (UM200905)
Phase I/II Study to evaluate the Safety and Efficacy of Zileuton (Zyflo) in a Combination with Imatinib Mesylate (Gleevec®) in Patients with Chronic Myelogenous Leukemia
INVESTIGATOR: Jan Cerny, MD, PhD
SPONSOR: University of Massachusetts Medical School
Imatinib/Zileuton in CML at clinicaltrials.gov
GSK WT1-AS01B-AML-002 (111727)
Study of GSK2130579 a Tumor-Antigen-Specific Cancer Immunotherapeutic in Adult Acute Myeloid Leukemia Patients with a Suboptimal Clinical Response to Induction Chemotherapy
INVESTIGATOR: Rajneesh Nath, MD
SPONSOR: GlaxoSmithKline Pharmaceutical
GSK WT1-AS01B-AML-002 at clinicaltrials.gov
Cellerant Therapeutics, Inc
A Phase I/II Trial of CLT-008 Myeloid Progenitor Cells in Patients Receiving Post-Remission Therapy for High Risk Leukemia or Myelodysplasia
INVESTIGATOR: Jan Cerny, MD
SPONSOR: Cellerant Therapeutics, Inc.
clinicaltrials.gov
Learn more about research and other clinical trials underway at the UMass Memorial Cancer Center of Excellence.
To learn more about clinical trials and cancer research, call 508-856-3216 or email cancer.research@umassmed.edu.